Curated by our team of international life sciences experts, Synapse features the latest legal and regulatory developments you need to know about.
Latest insights
Orphan drug protection: clarification needed
UK medicines – Is the Northern Ireland Protocol now unsustainable?
Taylor Wessing spearheads launch of new Trans-Pacific intellectual property guide
The UK and the Trans-Pacific Partnership – Could patent conflicts ruin the deal?
Available in English and Japanese
The EU torpedoes itself in cross-border patent disputes
Paul England and Simon Cohen launch new life sciences IP guide
mHealth apps – top tips for GDPR compliance
One Nucleus Genesis Digital 2020 – Key takeaways from our cell and gene therapy panel session
8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021
Biologics and biosimilars litigation update
Why developments in global trade will highlight patent enforcement in the UK and Trans-Pacific countries
The medical device regulatory regime in Great Britain and Northern Ireland after 31 December 2020
Tools and online services
EU Medical Device Regulation guides
The implementation of the EU Medical Device Regulation (MDR) and the EU In-Vitro Diagnostic Regulation (IVDR) is fast approaching, arriving in May 2021 and May 2022 respectively.
Our two comprehensive guides provide clarity for medical device and IVD companies who may find the sheer size and complexity of the regulations a substantial hurdle to their international expansion plans.
